Oramed Pharmaceuticals Inc. (ORMP) is a publicly traded Healthcare sector company. As of June 17, 2026, ORMP trades at $3.85 with a market cap of $157.16M and a P/E ratio of 2.49. ORMP moved +1.99% today. Year to date, ORMP is +29.55%; over the trailing twelve months it is +74.54%. Its 52-week range spans $1.82 to $5.01. Rallies surfaces ORMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Oramed Pharmaceuticals Inc. (ORMP) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ORMP moved +1.99% today.
| Metric | Value |
|---|---|
| Price | $3.85 |
| Market Cap | $157.16M |
| P/E Ratio | 2.49 |
| EPS | $1.53 |
| Dividend Yield | 0.25% |
| 52-Week High | $5.01 |
| 52-Week Low | $1.82 |
| Volume | 4.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.00M |
| Net Income | $64.02M |
| Gross Margin | 0.65% |
ORMP analyst coverage data. Average price target: $0.00.